David Abrams Abrams Capital Management
David Abrams is the founder of Abrams Capital Management, a Boston-based firm with a flexible value-oriented mandate. A former Baupost Group investor, he is known for concentrated positions and a willingness to hold cash or unconventional securities when public equities are unattractive. Abrams Capital’s filings are followed for high-conviction ideas across equities and special situations.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AABA
Altaba Inc
AABA
|
+$836M |
| 2 |
Teva Pharmaceuticals
TEVA
|
+$46M |
| 3 |
Camping World
CWH
|
+$3.38M |
Top Sells
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 26.28% |
| 2 | Consumer Discretionary | 21.29% |
| 3 | Financials | 15.1% |
| 4 | Communication Services | 9.59% |
| 5 | Utilities | 8.98% |
Similar funds
David Abrams's Q3 2019 Portfolio in Review
As of Q3 2019, David Abrams held 20 positions worth $3.57B, down 3% from $3.68B the previous quarter. Its ten largest holdings account for 78% of the portfolio.
David Abrams deployed $886M of net new capital in Q3 2019, opening 1 new position and adding to 2 existing holdings. Its largest new stake was Altaba Inc: 12,650,000 shares worth $246M.
By sector, the portfolio is most concentrated in Healthcare at 26% of assets, up from 25% a quarter earlier, followed by Consumer Discretionary and Financials.
- David Abrams's largest Q3 2019 buy was Altaba Inc: 12,650,000 shares worth $246M.
- David Abrams added most to Teva Pharmaceuticals in Q3 2019, an estimated $46M increase.
- David Abrams's ten largest holdings make up 78% of its $3.57B portfolio in Q3 2019.
- David Abrams opened 1 new position and closed 0 in Q3 2019.
- David Abrams's portfolio value fell 3% quarter-over-quarter to $3.57B.
Based on Abrams Capital Management's 13F filing for Q3 2019, filed 14 Nov 2019.